← Back to Search

Text Messaging + Patient Navigation for COVID-19

N/A

Waitlist Available

Led By Guilherme Del Fiol, MD PhD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Speak English or Spanish

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up year 1

Awards & highlights

Study Summary

This trial will use tech interventions to increase COVID-19 testing and vaccination uptake among underserved populations in Utah.

Who is the study for?

This trial is for adults who are current patients at participating community health centers, own a working cellphone, and have their number listed in the clinic's records. They must speak English or Spanish. Minors cannot participate.Check my eligibility

What is being tested?

The study tests if text messaging (TM) and patient navigation (PN) can increase COVID-19 testing among underserved populations. It compares different approaches like TM with PN versus TM alone to see which is more effective.See study design

What are the potential side effects?

Since this trial involves non-medical interventions such as text messaging and patient navigation services, there are no direct medical side effects associated with participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ year 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~year 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and year 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Testing

Secondary outcome measures

Reach- Accept Vaccine

Reach-Accept Testing

Reach-Engage Testing

+2 more

Trial Design

2Treatment groups

Active Control

Group I: Text Messaging (TM) + No Patient NavigationActive Control1 Intervention

Bidirectional text messaging with a one-touch response to connect patients to vaccination or mailed at-home rapid test kits for use as needed. Patients will not receive patient navigation.

Group II: Text Message (TM) + Request (RPN)Active Control2 Interventions

Bidirectional text messaging with a one-touch response to connect patients to vaccination or mailed at-home rapid test kits for use as needed. RPN will provide patients the opportunity to reply PERSON (for connection to a PN) in response to a TM offering connection to testing and/or vaccination.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,099 Previous Clinical Trials

1,736,653 Total Patients Enrolled

Association for Utah Community HealthOTHER

3 Previous Clinical Trials

262,395 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,910,470 Total Patients Enrolled

Media Library

Text Messaging (TM) + No Patient Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05533918 — N/A

Coronavirus Research Study Groups: Text Messaging (TM) + No Patient Navigation, Text Message (TM) + Request (RPN)

Coronavirus Clinical Trial 2023: Text Messaging (TM) + No Patient Navigation Highlights & Side Effects. Trial Name: NCT05533918 — N/A

Text Messaging (TM) + No Patient Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05533918 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any participants needed for this investigation?

"Affirmative, the clinical trial is actively recruiting according to data available on clinicaltrials.gov. The study was first published on December 15th 2022 and edited most recently on May 8th 2023. It requires 112479 individuals from a single site for participation."

Answered by AI

How many participants are being monitored in this clinical investigation?

"Affirmative, the information on clinicaltrials.gov asserts that this medical trial is actively enlisting participants. This study was initially announced on December 15th 2022 and edited most recently on May 8th 2023, with a requirement for 112479 patients to be recruited from 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Text Message Study

Guilherme Del Fiol 2022. "SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Text Message Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05533918.

All > Covid 19